Comparative Long-Term Prognosis of Acute Myocardial Infarction and Acute Aortic Dissection in a Population-Based Registry

Figure 1. Flowchart of study enrolment. AAD, acute aortic dissection; AMI, acute myocardial infarction.

Figure 2. Cumulative incidence of all-cause and cardiovascular mortality in patients with AMI and AAD. Kaplan–Meier curves between patients with AMI (red) and AAD (blue). Cumulative incidence of death from (A) any cause and (B) cardiovascular diseases. Dashed vertical lines indicate the cumulative event rates at 1-, 3-, and 5-year time points. Hazard ration (HR) and 95% confidence interval (CI) were estimated using a multivariable Cox proportional hazards model adjusting for age and sex, with AMI as the reference. AAD, acute aortic dissection; AMI, acute myocardial infarction.

Figure 3. Landmark analysis beyond 30 days. Patients who died within 30 days after the onset were excluded from the landmark analysis beyond 30 days. Cumulative incidence of death from (A) any cause and (B) cardiovascular diseases. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated by the multivariable Cox proportional hazard regression model adjusting for age and sex, with AMI as the reference. The colour coding is as follows: AMI (red) and AAD (blue). AAD, acute aortic dissection; AMI, acute myocardial infarction.

Figure 4. Cumulative incidence of all-cause mortality by treatment strategy in patients with AMI and AAD. Cumulative incidence curves for all-cause mortality according to treatment strategy in patients with (A) AMI and (B) AAD. Solid lines indicate treated patients (revascularization for AMI; surgical or endovascular treatment for AAD), and dashed lines indicate untreated patients. The colour coding is as follows: STEMI (dark red), NSTEMI (light red), type A AAD (dark blue), and type B AAD (light blue). AAD, acute aortic dissection; AMI, acute myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; STEMI, ST-elevation myocardial infarction.